Health Condition 1: G819- Hemiplegia, unspecified Health Condition 2: G811- Spastic hemiplegia Health Condition 3: G811- Spastic hemiplegia
Conditions
Interventions
Intervention1: Ekangavir Rasa 125 mg/ B.D. Shudha Gandhak,Parad Bhasma, Kataloha Bhasma,Vanga Bhasma,Naga Bhasma,Tamra Bhasma,Abhrak Basma ,Tikshnaloh Bhasma,Shunthi,Pimpali,Marich.
2)Vaitarana Basti
Sponsors
Govenment Ayurved College Nagpur
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients having signs and symptoms of hemiplegia i.e. Pakshavadh mentioned in Ayurvedic texts. 2. Patient having muscle power grade less or equal to 3 3. Patients of hemiplegia i.e. Pakshavadh due to cerebral thrombosis. 4. Patients of hemiplegia i.e. Pakshavadh of duration not more than 5 years. 5. Patients of either sex aged between 21 years -70 year. 6. Patient willing and able to participate in the study. 7. Patients who have not participated in any research project in last 6 months. 8. Patients of hemiplegia i.e. Pakshavadh having controlled hypertension (systolic upto140 mm of Hg and diastolic up to 90 mm of Hg) and diabetes mellitus (BSL fasting up to 130 mg/dl and Post Prandial up to 180 mg/dl).
Exclusion criteria
Exclusion criteria: 1.Patients of cerebral infraction due to atrial fibrillation, embolic stroke, carotid occlusion, cerebellar stroke and haemorrhagic stroke will be excluded. 2.Patients having seizers, hydrocephalous, pulmonary embolism, dysphagia, M.I., cardiac arrhythmia and septicaemia will be excluded. 3.Patients who have lost bowel and bladder control. 4.Patients having acute progressive cerebral infarction 5.Comatose and unconscious patients. 6.Patients having age 70 years will be excluded. 7.Patients having intra cranial infection, encephalitis and meningitis etc. 8.Patient having trauma, cerebral tumour, cerebral abscess. 9.Patient with congenital heart diseases like POA, ASD, VSD and FOD. 10.Patients contraindicated for Abhyanga like skin diseases, infective disease will be excluded. 11.Patients not fit for Basti. 12.Pregnant and lactating mothers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To evaluate the effect of Ekangavir Rasa, Vaitarana Basti and Shirobasti in combination on Barthel Index and NIH Stroke Scale of Pakshavadh with special reference to Cerebral Infarction. 2.To evaluate the effect of Ekangavir Rasa with Vaitarana Basti on Barthel Index and NIH Stroke score of Pakshavadh with special reference to Cerebral Infarction.Timepoint: 1) For trial Group Snehan Svedan with Til tail, Vaitarana Basti along with Shirobasti given for 16 days and Ekangavir Rasa 125 mg for 30 days 2) For Control Group Snehan Svedan with Til tail, Vaitarana Basti given for 16 days and Ekangavir Rasa 125 mg for 30 days 3) On day zero which will be termed as B.T. Value, second assessment will be done on 17th day and Final Assessment will be done on 31st day. | — |
Secondary
| Measure | Time frame |
|---|---|
| To review and study literature of Pakshvadh.Timepoint: one and half year. | — |
Countries
India
Contacts
Public ContactAshish Thatere
Government Ayurved College Nagpur
Outcome results
None listed